RET and medullary thyroid gland carcinoma: The American Thyroid Association guidelines (2015) for managing MTC list the relationships between important RET gene mutations and aggressiveness of MTC and incidence of PCC and other related tumors, in order to provide clinical guidance on the management of MEN patients [10].